Richard C Lindsey1,2,3, Subburaman Mohan4,5,6. 1. Musculoskeletal Disease Center, VA Loma Linda Healthcare System, Loma Linda, CA, USA. 2. Division of Biochemistry, Department of Basic Sciences, School of Medicine, Loma Linda University, Loma Linda, CA, USA. 3. Center for Health Disparities and Molecular Medicine, Department of Basic Sciences, School of Medicine, Loma Linda University, Loma Linda, CA, USA. 4. Musculoskeletal Disease Center, VA Loma Linda Healthcare System, Loma Linda, CA, USA. Subburaman.Mohan@va.gov. 5. Division of Biochemistry, Department of Basic Sciences, School of Medicine, Loma Linda University, Loma Linda, CA, USA. Subburaman.Mohan@va.gov. 6. Center for Health Disparities and Molecular Medicine, Department of Basic Sciences, School of Medicine, Loma Linda University, Loma Linda, CA, USA. Subburaman.Mohan@va.gov.
Abstract
PURPOSE: Mutant hypothyroid mouse models have recently shown that thyroid hormone is critical for skeletal development during an important prepubertal growth period. Additionally, thyroid hormone negatively regulates total body fat, consistent with the well-established effects of thyroid hormone on energy and fat metabolism. Since bone marrow mesenchymal stromal cells differentiate into both adipocytes and osteoblasts and a relationship between bone marrow adipogenesis and osteogenesis has been predicted, we hypothesized thyroid hormone deficiency during the postnatal growth period increases marrow adiposity in mice. METHODS: Marrow adiposity in TH-deficient (Tshr -/-) mice treated with T3/T4, TH receptor β-specific agonist GC-1, or vehicle control was evaluated via dual-energy X-ray absorptiometry and osmium micro-computed tomography. To further examine the mechanism for thyroid hormone regulation of marrow adiposity, we used real-time RT-PCR to measure the effects of thyroid hormone on adipocyte differentiation markers in primary mouse bone marrow mesenchymal stromal cells and two mouse cell lines in vitro and in Tshr -/- mice in vivo. RESULTS: Marrow adiposity increased >20% (P < 0.01) in Tshr -/- mice at 3 weeks of age, and treatment with T3/T4 when serum thyroid hormone normally increases (day 5-14) rescued this phenotype. Furthermore, GC-1 rescued this phenotype equally well, suggesting this thyroid hormone effect is in part mediated via TRβ signaling. Treatment of bone marrow mesenchymal stromal or ST2 cells with T3 or GC-1 significantly increased expression of several brown/beige fat markers. Moreover, injection of T3/T4 increased browning-specific markers in white fat of Tshr -/- mice. CONCLUSIONS: These data suggest that thyroid hormone regulation of marrow adiposity is mediated at least in part via activation of TRβ signaling.
PURPOSE: Mutant hypothyroid mouse models have recently shown that thyroid hormone is critical for skeletal development during an important prepubertal growth period. Additionally, thyroid hormone negatively regulates total body fat, consistent with the well-established effects of thyroid hormone on energy and fat metabolism. Since bone marrow mesenchymal stromal cells differentiate into both adipocytes and osteoblasts and a relationship between bone marrow adipogenesis and osteogenesis has been predicted, we hypothesized thyroid hormone deficiency during the postnatal growth period increases marrow adiposity in mice. METHODS: Marrow adiposity in TH-deficient (Tshr -/-) mice treated with T3/T4, TH receptor β-specific agonist GC-1, or vehicle control was evaluated via dual-energy X-ray absorptiometry and osmium micro-computed tomography. To further examine the mechanism for thyroid hormone regulation of marrow adiposity, we used real-time RT-PCR to measure the effects of thyroid hormone on adipocyte differentiation markers in primary mouse bone marrow mesenchymal stromal cells and two mouse cell lines in vitro and in Tshr -/- mice in vivo. RESULTS: Marrow adiposity increased >20% (P < 0.01) in Tshr -/- mice at 3 weeks of age, and treatment with T3/T4 when serum thyroid hormone normally increases (day 5-14) rescued this phenotype. Furthermore, GC-1 rescued this phenotype equally well, suggesting this thyroid hormone effect is in part mediated via TRβ signaling. Treatment of bone marrow mesenchymal stromal or ST2 cells with T3 or GC-1 significantly increased expression of several brown/beige fat markers. Moreover, injection of T3/T4 increased browning-specific markers in white fat of Tshr -/- mice. CONCLUSIONS: These data suggest that thyroid hormone regulation of marrow adiposity is mediated at least in part via activation of TRβ signaling.
Entities:
Keywords:
Adiposity; Bone density; Bone marrow stromal cells; Brown/beige fat; Obesity; Thyroid hormone; Thyroid hormone receptor beta
Authors: Tishya A L Wren; Sandra A Chung; Frederick J Dorey; Stefan Bluml; Gregor B Adams; Vicente Gilsanz Journal: J Clin Endocrinol Metab Date: 2010-12-22 Impact factor: 5.958
Authors: Erica L Scheller; Nancy Troiano; Joshua N Vanhoutan; Mary A Bouxsein; Jackie A Fretz; Yougen Xi; Tracy Nelson; Griffin Katz; Ryan Berry; Christopher D Church; Casey R Doucette; Matthew S Rodeheffer; Ormond A Macdougald; Clifford J Rosen; Mark C Horowitz Journal: Methods Enzymol Date: 2014 Impact factor: 1.600
Authors: J H Duncan Bassett; Allan J Williams; Elaine Murphy; Alan Boyde; Peter G T Howell; Rowan Swinhoe; Marta Archanco; Frédéric Flamant; Jacques Samarut; Sabine Costagliola; Gilbert Vassart; Roy E Weiss; Samuel Refetoff; Graham R Williams Journal: Mol Endocrinol Date: 2007-10-11
Authors: Kinga Lénárt; Csaba Bankó; Gyula Ujlaki; Szilárd Póliska; Gréta Kis; Éva Csősz; Miklós Antal; Zsolt Bacso; Péter Bai; László Fésüs; András Mádi Journal: Int J Mol Sci Date: 2022-05-05 Impact factor: 6.208